Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
By A. Cassini, L. Högberg, D. Plachouras, A. Quattrocchi, Ana Hoxha, G. S. Simonsen, M. Colomb-Cotinat, Mirjam E. Kretzschmar, B. Devleesschauwer, M. Cecchini and 70 more. Lancet. Infectious Diseases (Print), 2019
2,398 citations recorded by the source corpus.
Summary Background Infections due to antibiotic-resistant bacteria are threatening modern health care. However, estimating their incidence, complications, and attributable mortality is challenging. We aimed to estimate the burden of infections caused by antibiotic-resistant bacteria of public health concern in countries of the EU and European Economic Area (EEA) in 2015, measured in number of cases, attributable deaths, and disability-adjusted life-years (DALYs). Methods We estimated the incidence of infections with 16 antibiotic resistance–bacterium combinations from European Antimicrobial Resistance Surveillance Network (EARS-Net) 2015 data that was country-corrected for population coverage. We multiplied the number of bloodstream infections (BSIs) by a conversion factor derived from the European Centre for Disease Prevention and Control point prevalence survey of health-care-associated infections in European acute care hospitals in 2011–12 to estimate the number of non-BSIs. We developed disease outcome models for five types of infection on the basis of systematic reviews of the literature. Findings From EARS-Net data collected between Jan 1, 2015, and Dec 31, 2015, we estimated 671 689 (95% uncertainty interval [UI] 583 148–763 966) infections with antibiotic-resistant bacteria, of which 63·5% (426 277 of 671 689) were associated with health care. These infections accounted for an estimated 33 110 (28 480–38 430) attributable deaths and 874 541 (768 837–989 068) DALYs. The burden for the EU and EEA was highest in infants (aged <1 year) and people aged 65 years or older, had increased since 2007, and was highest in Italy and Greece. Interpretation Our results present the health burden of five types of infection with antibiotic-resistant bacteria expressed, for the first time, in DALYs. The estimated burden of infections with antibiotic-resistant bacteria in the EU and EEA is substantial compared with that of other infectious diseases, and has increased since 2007. Our burden estimates provide useful information for public health decision-makers prioritising interventions for infectious diseases. Funding European Centre for Disease Prevention and Control.
Subfields: Applied Microbiology and Biotechnology, Epidemiology, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/6b3079e1fb81719ff0077032bc01287709e7e392
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Microbiology and Biotechnology
In Epidemiology
In Molecular Medicine
Citations in the corpus
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis (2022, methodology): “6,10 When assessed by super-region, however, our results are much more consistent with the published literature: similar to the CDC and ECDC, we found the burden of third-generation cephalosporin-resistant E coli to exceed that of carbapenem-resistant A baumannii in high-income settings, whereas…”
- Antimicrobial Resistance in ESKAPE Pathogens (2020, background): “(UTI) in both community and health care settings globally (5, 35, 64).”
- Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 (2024, neutral): “These include estimates from the US Centers for Disease Control and Prevention, which evaluated 18 AMR threats in 2013 and 2019, and from Cassini and colleagues, 9 who produced AMR estimates for the European Union and European Economic Area in 2007 and 2015 for 16 pathogen–drug combinations.”
- Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread (2019, background): “pneumoniae represents the fastest growing antibiotic resistance threat in Europe, in terms of human morbidity and mortality [2].”